PYGB and NCK2 are both upregulated in IBD, where PYGB is known to regulate the WNT/β-catenin pathway, and NCK2 is involved in integrin and epidermal growth factor receptor signalling78–80. Here, EGFR is linked to irritable bowel syndrome.